ǰÑÔ
²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡£¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ£¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒߣ¬¿Éͬʱ»òÏȺóѬȾ£¬»ìÏýѬȾ»òÖØµþѬȾ£¬Ê¹Ö¢×´¼ÓÖØ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷࣿÚÈö²¥ÎªÖ÷£¬³£¼û·¢ÈÈ¡¢»Æ¾Ò£¬³Ê¼±ÐÔ¾ÓÉ£¬ÓÐÊýǨÑÓ³ÉÂýÐÔ£»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ×£¬¶à¾ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥£¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯£¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ£»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ£¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó¡£
ÎìÐ͸ÎÑ×(hepatitis E)ÊÇÓÉÓÚѬȾÁËÎìÐ͸ÎÑײ¡¶¾(hepatitis E virus,HEV)Ëùµ¼ÖµÄÒ»ÖÖÑÏÖØµÄ¸ÎÔ༲²¡¡£ÎìÐ͸ÎÑײ¡¶¾ÊÇÒ»ÖÖСRNA²¡¶¾£¬Óë¼×Ð͸ÎÑײ¡¶¾Èö²¥Ñ¬È¾·½·¨ÏàËÆ£¬¶¼ÊÇͨ¹ý·à£¿Ú;¾¶£¬Ò²¿ÉÄÜÊÇÓÉÓÚѪҺѬȾ£¬Í¨³£»áµ¼ÖÂÑÏÖØµÄѬȾ¡£ÔÝʱûÓÐÕë¹ØÓÚÎìÐ͸ÎÑײ¡¶¾²¢Í¨¹ýFDA Åú×¼µÄÒßÃç¡£ÎìÐ͸ÎÑ×µÄÖ÷ÒªÖ¢×´Óз¢ÈÈ¡¢Òׯ£ÀÍ¡¢Ê³Óû²»Õñ¡¢¶ñÐÄ¡¢ÍÂÄæ¡¢¸¹Í´¡¢»Æ¾Ò¡¢Ð¡±ã»Æ³à¡¢ÊàŦʹµÈ¡£Ñ¬È¾ºóéæÃüÂÊԼĪΪ1%£¬µ«Ôи¾Ñ¬È¾»áµ¼Ö±©·¢ÐÔ¸ÎÑ×ÉõÖÁéæÃü£¬ÔÚÍíÆÚÈÑÉïµÄ¸¾Å®ÖУ¬éæÃüÂʵִï10%~30%¡£ÒÑ»¼ÓÐÂýÐÔ¸ÎÔ༲²¡µÄÈËѬȾÎìÐ͸ÎÑ׺ó¿ÉÄܻᵼÖ´úлÔÓÂÒ»òéæÃü¡£ÏÖÔÚÓÃÓÚ½¨ÉèÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÎïÖÖÖ÷ÒªÓкÚÐÉÐÉ¡¢ºãºÓºï¡¢Ê³Ð·ºï¡¢áõºï¡¢Öí¡¢¾ÞϸÊóµÈ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎºãºÓºï
¡¾ÔìÄ£»úÖÆ¡¿£º
ÎìÐ͸ÎÑ×Ö÷Òª¾·à£¿Ú;¾¶£¨Ïû»¯µÀ£©Èö²¥£¬ÆäËû;¾¶ÓÐѪҺÈö²¥¡¢±ÊÖ±Èö²¥µÈ¡£Ê¹ÓÃÎìÐ͸ÎÑ×µÄÈö²¥Ìص㣬ͨ¹ýÏò¶¯Îï¾²Âö×¢ÉäÎìÐ͸ÎÑ×»¼ÕßÐÂÏÊ´ó±ãÂËÒºµÄÒªÁìÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾÎìÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
È¡ÎìÐ͸ÎÑ×»¼Õß¼±ÐÔÆÚ·à±ãÑùÆ·£¬ÒÔ0.1mol/L PBS»º³åÒºÖÆ³É10£¥ÐüÒº£¬¾ÀëÐÄ¡¢Â˾úºó£¬ÒÔ1.5ml/Ö»¼ÁÁ¿¾ºóÖ«¾²Âö×¢ÉäºãºÓºï(rhesus monkey)¡£
¡¾Ä£×ÓÌØµã¡¿£º
ѬȾºóµÚ28Ìì×óÓÒ£¬ALT×îÏÈÉý¸ß£¬1ÖÜÃÜ´ï·åÖµ£¬µÚ18~28Ìì×óÓÒ£¬IgGÑôÐÔ£¬120Ìì»Ö¸´Õý³££¬14~32Ìì·ºÆð²¡¶¾ÑªÖ¢¡£Ñ¬È¾ºóµÚ7~55Ìì·à±ãÅŶ¾£¬·à±ãÑùÆ·µç¾µÊӲ쵽27~34nmµÄ²¡¶¾Ñù¿ÅÁ£¡£¸Î³¬±¡×éÖ¯ÇÐÆ¬µç¾µÊӲ췢Ã÷¸Îϸ°ûÖÊÖб£´æÎìÐ͸ÎÑײ¡¶¾¾ÞϸµÄ²¡¶¾Ñù¿ÅÁ££¬ÏûÈÚ»µËÀµÄµ¨ÄÒÉÏÆ¤Ï¸°ûË鯬Öпɼû³É´ØÈº¼¯ÔÚÒ»ÆðµÄ²¡¶¾¿ÅÁ£¡£¸Î²¡ÀíÇÐÆ¬¿ÉÊӲ쵽¸ÎʵÖÊËÉÉ¢»µËÀ£¬´ó×ÚÁܰÍϸ°ûºÍÉÙÁ¿ÖÐÐÔÁ£Ï¸°ûÔîÐÔ½þÈó£¬ÖÐÑë¾²Âö±Ú±»ÆÆËð£¬ÁܰÍϸ°û½þÈ󣬻ã¹ÜÇøÑ×֢ϸ°û½þÈó¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ÔÚÎìÐ͸ÎÑ×·ÇÈËÀàÁ鳤ÀදÎïÄ£×ÓÖУ¬ÎÒ¹úÒ»Ñùƽ³£¶¼½ÓÄɺãºÓºï×÷Ϊ¶¯ÎïÄ£×Ó£¬ºãºÓºïÎìÐ͸ÎÑ×¶¯ÎïÄ£×Ó¿ÉÓÃÓÚÁÙ´²Õï¶Ï¡¢¼²²¡Ô¤·À¡¢ÒßÃçÑз¢¡£
²Î¿¼ÎÄÏ×£º
1.Äϴ󺽣¬ÅËÄþ£¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬2012, 31 (4):504-507
2.¹¢¼Ò±¦£¬ÍõÁᣬÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾£¬2010, 11(4):429-432
3.Õ²ÃÀÔÆ£¬Áõ³ç°Ø£¬Àî³ÉÃ÷£¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨£¬1981, 3 (3):148-152
4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97
5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988
6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211
7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128
8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177